Sunday, September 7, 2025

Common allergy spray slashes COVID-19 risk in surprising trial

A common hay fever nasal spray was found to cut COVID-19 infections by two-thirds in a clinical trial, while also reducing rhinovirus cases. Researchers believe it could serve as an easy, low-cost preventive measure, pending further studies.

from Top Health News -- ScienceDaily https://ift.tt/fDmxMdH

No comments:

Post a Comment

Scientists create “smart” DNA drug that targets cancer cells with extreme precision

Scientists have created a programmable drug system that can zero in on cancer cells with unprecedented accuracy. Built from synthetic DNA, i...